Clinical Trials Logo

Tick-Borne Encephalitis clinical trials

View clinical trials related to Tick-Borne Encephalitis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04017052 Active, not recruiting - Clinical trials for Tick Borne Encephalitis

Application of a TBE-Vaccine in Obese Persons

Start date: April 15, 2015
Phase: Phase 4
Study type: Interventional

Obese people have an altered immune responsiveness. The present study investigates whether this influences immune responses to booster vaccinations (i. e. booster vaccination with TBE vaccine "FSME Immun") and if a modification of vaccination schedules is needed. Obese adults (BMI >30) >18 - 60 years are compared with adults with normal weight (BMI <25) concerning TBE-NT- antibody titers, TBE- NT antibody titer course and cellular immunity. Metabolic parameters and sexual hormones will be tested and compared as well.

NCT ID: NCT00890422 Active, not recruiting - Clinical trials for Tick Borne Encephalitis

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine

immunisation
Start date: March 2007
Phase: Phase 2
Study type: Interventional

The study aims to answer this question: whether adequate immunity can be achieved in a short time, that is, by a rapid immunisation process, using at least one of 3 new TBE immunisation schedules? The investigators will test the immunogenicity (the degree of immunity achieved) of each of the immunisation schedules at various times after the injections. If the results of this clinical study are positive, it may then be possible to develop the most successful immunisation schedule so that it can be used routinely. This means that the results of the clinical study have an enormous practical value in preventing TBE in people travelling or moving into areas with a high TBE risk.